Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?

Transl Cancer Res. 2020 Apr;9(4):2171-2174. doi: 10.21037/tcr.2020.02.31.

Authors

Kimia Mirzakhani¹, Aria Baniahmad¹

Affiliation

¹ Institute of Human Genetics, Jena University Hospital, Jena, Germany.

No abstract available

Publication types

Editorial
Comment